Michael Seth Altman - 14 Jun 2024 Form 4 Insider Report for Nautilus Biotechnology, Inc. (NAUT)

Role
Director
Signature
/s/ Samuel M. Cohn, as Attorney-in-Fact for Michael Seth Altman
Issuer symbol
NAUT
Transactions as of
14 Jun 2024
Transactions value $
$0
Form type
4
Date filed
17 Jun 2024, 18:03
Previous filing
13 Jun 2024
Next filing
31 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NAUT Stock Option (Right to Buy) Award $0 +45K $0.00 45K 14 Jun 2024 Common Stock 45K $2.56 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to reporting person's continuous status as a "Service Provider" (as defined in the Issuer's 2021 Equity Incentive Plan) through each applicable vesting date, one-twelfth (1/12th) of the shares subject to the Option shall vest on a monthly basis following the date of grant on the same day of the month as such grant date.